|Articles|October 15, 2020
Initial Development of SARS-CoV-2 Antigen Assay Using BAMS Technology and MALDI-TOF
Author(s)Bruker Corporation
This work is focused on the development of a novel SARS-CoV-2 spike glycoprotein assay based on BAMS™ assay platform with detection by MALDI-TOF MS.
Trending on LCGC International
1
HPLC, PTR-ToF-MS Enable AI Grading of White Tea
2
Py-GC–MS Reveals Microplastics in Playgrounds
3
Analytical Procedure Lifecycle Approaches in Accordance With ICH Q14 and ICH Q2(R2): Opportunity Knocks or Just Another Challenge and Headache? (Part 2)
4
LC-MS/MS Links Vitamin D Levels to Sleep Timing
5